News on this topic
FDA vaccine chief Vinay Prasad leaves following criticism from Laura Loomer: Dr. Vinay Prasad is stepping down as the Food and Drug Administration’s top vaccine ...
apnews.com/article/vinay-prasad-fda-vaccines-laura-loomer-83030ad6eb7651095e3c40444dd69f12

Vinay Prasad Was Too MAHA for the Trump Administration: Vinay Prasad was supposed to be the guy who kept Big Pharma in check. Now he’s gone.
theatlantic.com/health/archive/2025/07/vinay-prasad-maha-trump/683715/
Top F.D.A. Official Resigns Under Pressure: After turning down several new drugs and restricting use of another, Dr. Vinay Prasad drew the ire of the right-wing ...
nytimes.com/2025/07/29/health/vinay-prasad-fda-resigns-loomer.html

More articles on this subject
Previous
Trump Straight Up Ignored RFK Jr. to Fire Top Vaccine Regulator: Both the health secretary and FDA commissioner urged the president not to remove Dr ...
thedailybeast.com/donald-trump-straight-up-ignored-rfk-jr-to-fire-top-vaccine-regulator-vinay-prasad/

Controversial FDA official Dr. Vinay Prasad departs agency: Dr. Vinay Prasad, the controversial critic of the US Food and Drug Administration who took a top role ...
edition.cnn.com/2025/07/29/health/vinay-prasad-fda

US FDA's chief medical and science officer Prasad departs agency: Vinay Prasad, the U.S. Food and Drug Administration's chief medical and science officer ...
reuters.com/business/healthcare-pharmaceuticals/us-fdas-chief-medical-science-officer-prasad-departs-agency-2025-07-30/

FDA’s top vaccine regulator departs amid conservative criticism: Vinay Prasad, the top vaccine regulator and chief scientific officer at the Food and Drug ...
thehill.com/policy/healthcare/5427311-vinay-prasad-vaccine-regulator-resigns-fda/

Controversial FDA vaccine chief departs agency after less than 3 months: Dr. Vinay Prasad is stepping down as the Food and Drug Administration’s top vaccine ...
pbs.org/newshour/politics/controversial-fda-vaccine-chief-departs-agency-after-less-than-3-months

FDA vaccine chief leaving agency after less than 3 months: Dr. Vinay Prasad is stepping down as the Food and Drug Administration’s top vaccine regulator after a ...
twincities.com/2025/07/30/fda-vaccine-chief-leaves-agency/

FDA vaccine chief leaving agency: Dr. Vinay Prasad “did not want to be a distraction” and was stepping down from his role as the FDA’s top vaccine regulator “to ...
bostonglobe.com/2025/07/30/nation/fda-vaccine-chief-leaving-agency/

Controversial vaccine official Dr. Vinay Prasad departs FDA: Dr. Vinay Prasad had been serving as the FDA's director of the Center for Biologics Evaluation and ...
cbsnews.com/news/vinay-prasad-out-fda-vaccine-official-trump-laura-loomer/
US FDA's top vaccine official Vinay Prasad leaves agency after short stint: The U.S. Food and Drug Administration's top official, Vinay Prasad ...
reuters.com/business/healthcare-pharmaceuticals/us-fdas-top-vaccine-official-vinay-prasad-leaves-agency-after-short-stint-2025-07-30/

Top FDA Official Leaves Job After Laura Loomer’s Attacks: Even with Robert F. Kennedy Jr.’s backing, Dr. Vinay Prasad couldn’t weather Storm Loomer.
thedailybeast.com/top-fda-official-vinay-prasad-leaves-job-after-laura-loomers-attacks/
Top FDA Official Appointed By Trump Admin Departs After Three Months: A spokesperson for the Health Department has said that Vinay Prasad did not want to be a ...
newsweek.com/vinay-prasad-departs-fda-after-less-three-months-2106204

Who is Vinay Prasad, Indian-origin FDA official who resigned after campaign by right-wing influencer Laura Loomer?
wionews.com/world/who-is-vinay-prasad-indian-origin-fda-official-who-resigned-after-campaign-by-right-wing-influencer-laura-loomer-1753867702069

Next
Similar to This
Previous
"Truly evil" FDA rejection of gene therapy overturned after Trump official ousted
arstechnica.com/health/2026/06/truly-evil-fda-rejection-of-gene-therapy-overturned-after-trump-official-ousted/

OpinionAnother Marty Makary Mistake: The FDA chief names Vinay Prasad’s deputy to replace him.
wsj.com/opinion/marty-makary-vinay-prasad-katherine-szarama-fda-2f70e24d
Paid articlePaywallUS FDA taps Szarama as acting head of vaccine unit: The U.S. Food and Drug Administration has named Katherine Szarama as the acting director of its vaccines and ...
reuters.com/legal/litigation/us-fda-taps-szarama-acting-head-vaccine-unit-politico-reports-2026-05-01/

FDA's Makary expects decision on Prasad successor in coming weeks: U.S. Food and Drug Administration Commissioner Marty Makary said on Tuesday there had been no ...
reuters.com/business/healthcare-pharmaceuticals/fdas-makary-expects-decision-prasad-successor-coming-weeks-2026-04-28/

Trump's divisive FDA vaccine regulator self-destructs, will exit agency (again): It's unclear what Prasad's FDA exit means, but some drug makers are happy to see ...
arstechnica.com/health/2026/03/trumps-divisive-fda-vaccine-regulator-self-destructs-will-exit-agency-again/

Vinay Prasad, key Makary ally and a focus of controversy at the FDA, is leaving the agency
statnews.com/2026/03/06/fda-vinay-prasad-controversial-cber-director-leaving/

Key FactsFDA Vaccine Chief Prasad Resigns Amid Controversies
Mar 7, 2026 · Reading time: ~45 sec.
Summary created with AI assistance · Source: cbsnews.com
Summary created with AI assistance · Source: cbsnews.com
- Dr. Vinay Prasad is stepping down from his role as FDA vaccine chief for the second time in less than a year.
- His departure follows controversial actions such as initially rejecting Moderna’s mRNA flu vaccine and requiring new trials for gene therapies.
- The FDA recently engaged in a rare public dispute over a Huntington’s disease treatment, raising ethical issues about sham surgeries.
- Prasad’s tenure saw tightened study demands amid criticism from drugmakers, despite efforts to speed up FDA drug approval processes.
We have a failed product here.— Anonymous senior FDA official, speaking to reporters about UniQure's Huntington's disease gene therapy and the FDA's demand for an additional study.
Exclusive | FDA’s Controversial Vaccines Chief Will Leave the Agency: Dr. Vinay Prasad will depart in April, after a year leading the division that approves ...
wsj.com/health/healthcare/fdas-controversial-vaccines-chief-will-leave-the-agency-7fe59aa3

Paid articlePaywallFDA Commissioner Marty Makary defends rare disease drug rejections, Vinay Prasad: Makary appeared to reference the FDA’s stance on a gene therapy made by UniQure ...
statnews.com/2026/02/26/makary-fda-rare-disease-vinay-prasad-cnbc/

Paid articlePaywallFDA Ties 10 Child Deaths to COVID Vaccine: Report: FDA chief medical officer Vinay Prasad told reporters that the agency would be changing its vaccine approval ...
newsweek.com/fda-10-child-deaths-covid-vaccine-11131150

Murdoch Paper Warns RFK Jr. Henchman Will ‘Cost Many Lives’: The Wall Street Journal warns that a plan to ax experimental cancer treatments and biotech research ...
thedailybeast.com/wall-street-journal-torches-robert-f-kennedy-jr-lackeys-plot-as-scandal-that-will-cost-many-lives/

Vinay Prasad regains role as FDA chief medical officer: Vinay Prasad has regained his role as the U.S. Food and Drug Administration's chief medical and ...
reuters.com/business/healthcare-pharmaceuticals/vinay-prasad-regains-role-fda-chief-medical-officer-2025-09-11/

Trump’s ‘Ice Maiden’ Shows Laura Loomer Who’s in Charge : Donald Trump’s chief of staff Susie Wiles has won the latest round in MAGA’s civil war.
thedailybeast.com/trumps-ice-maiden-susie-wiles-wins-latest-round-in-maga-civil-war-over-laura-loomer/

Vinay Prasad Returns To Role As Top Vaccine Regulator At FDA Days After Leaving U.S. Agency
huffpost.com/entry/vinay-prasad-vaccine-regulator-fda_n_6897b873e4b041ecaf505cb3

Key FactsDr. Vinay Prasad Reinstated at FDA Leadership
Aug 9, 2025 · Reading time: ~45 sec.
Summary created with AI assistance · Source: nytimes.com
Summary created with AI assistance · Source: nytimes.com
- Dr. Vinay Prasad, former head of the FDA's vaccines and gene therapy division, has returned to the agency two weeks after resigning.
- His departure followed targeted criticism from activist Laura Loomer and disputes over medication approvals and comments about President Trump.
- Health officials defended Prasad despite the backlash, emphasizing his role in limiting COVID vaccine use to high-risk groups.
- The rehiring reflects the continuing influence of Health Secretary Robert F. Kennedy Jr. and FDA Commissioner Dr. Marty Makary.
Dr. Makary called him an 'impeccable scientist.'— Dr. Makary about Dr. Vinay Prasad regarding his return to the FDA.
Top Vaccine Regulator Rehired at FDA After Laura Loomer Dubbed Him A ‘Trump-Hating Bernie Bro’
mediaite.com/politics/top-vaccine-regulator-rehired-at-fda-after-laura-loomer-dubbed-him-a-trump-hating-bernie-bro/

FDA’s Prasad Exits Following Political Backlash Over Sarepta: Vinay Prasad, a top regulator at the US Food and Drug Administration, left the agency after a ...
bloomberg.com/news/articles/2025-07-30/fda-s-vinay-prasad-exits-after-sarepta-gene-therapy-controversy

Paid articlePaywallFDA vaccine official restricted COVID vaccine approvals against the advice of agency staff
trib.al/env6Cnz

An Anti-Science MAHA Extremist Is Playing a Major Role at the FDA
: On first glance, Dr. Vinay Prasad’s medical credentials sound impressive ...
newrepublic.com/article/194979/vinay-prasad-fda-trump-vaccines

FDA Appointee Vinay Prasad Is a Drug Critic With a Lot to Prove: Vinay Prasad oversees vaccines, gene therapies and the blood supply. His views raise alarms for ...
bloomberg.com/opinion/articles/2025-05-13/fda-appointee-vinay-prasad-is-a-drug-critic-with-a-lot-to-prove

Paid articlePaywallUS FDA names oncologist Vinay Prasad as top vaccine official: The US Food and Drug Administration has named Vinay Prasad, an oncologist who has previously ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-names-oncologist-vinay-prasad-top-vaccine-official-2025-05-06/

Drug ETF Bet Pays Off on FDA Vaccine Chief Prasad Appointment: An unusually large bearish bet on a drug ETF gained almost $800,000 as drug stocks reeled ...
bloomberg.com/news/articles/2025-05-06/well-timed-bearish-drug-etf-bet-pays-off-on-vaccine-chief-news

Paid articlePaywall Next